Search research articles
Contact Us
Filters
Showing results (201-210 of 483) with videos related to
Page
of 49
Sort By:
JMIR Public Health and Surveillance
|
February 14, 2024
Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey
Maurizio Macaluso, Marc E Rothenberg, Thomas Ferkol, et al.
European Journal of Immunology
|
June 20, 2006
The role of Th2 cytokines, chemokines and parasite products in eosinophil recruitment to the gastrointestinal mucosa during helminth infection
Helen Dixon, Carine Blanchard, Matthew L Deschoolmeester, et al.
The Journal of Allergy and Clinical Immunology
|
June 19, 2026
Tissue remodeling in eosinophilic esophagitis
Seema Aceves, Mario C Manresa, Evan S Dellon, et al.
IEEE Open Journal of Engineering in Medicine and Biology
|
September 10, 2021
Machine Learning Approach for Biopsy-Based Identification of Eosinophilic Esophagitis Reveals Importance of Global features
Tomer Czyzewski, Nati Daniel, Mark Rochman, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 25, 2020
Eosinophilic Esophagitis Histology Remission Score: Significant Relations to Measures of Disease Activity and Symptoms
Margaret H Collins, Lisa J Martin, Ting Wen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2013
IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop
Carine Bouffi, Mark Rochman, Christopher B Zust, et al.
Allergy
|
February 16, 2023
Protease allergens as initiators-regulators of allergic inflammation
Wai Tuck Soh, Jihui Zhang, Morley D Hollenberg, et al.
Blood
|
January 19, 2006
The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease
Yoshiyuki Yamada, Marc E Rothenberg, Andrew W Lee, et al.
The Journal of Allergy and Clinical Immunology
|
April 16, 2008
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels
Miguel L Stein, Joyce M Villanueva, Bridget K Buckmeier, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
August 9, 2020
Early life factors are associated with risk for eosinophilic esophagitis diagnosed in adulthood
Evan S Dellon, Olivia Shaheen, Nathaniel T Koutlas, et al.
Page
of 49
Search research articles
Search
Showing results (201-210 of 483) with videos related to
Sort By:
Page
of 49
JMIR Public Health and Surveillance
|
February 14, 2024
Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey
Maurizio Macaluso, Marc E Rothenberg, Thomas Ferkol, et al.
European Journal of Immunology
|
June 20, 2006
The role of Th2 cytokines, chemokines and parasite products in eosinophil recruitment to the gastrointestinal mucosa during helminth infection
Helen Dixon, Carine Blanchard, Matthew L Deschoolmeester, et al.
The Journal of Allergy and Clinical Immunology
|
June 19, 2026
Tissue remodeling in eosinophilic esophagitis
Seema Aceves, Mario C Manresa, Evan S Dellon, et al.
IEEE Open Journal of Engineering in Medicine and Biology
|
September 10, 2021
Machine Learning Approach for Biopsy-Based Identification of Eosinophilic Esophagitis Reveals Importance of Global features
Tomer Czyzewski, Nati Daniel, Mark Rochman, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 25, 2020
Eosinophilic Esophagitis Histology Remission Score: Significant Relations to Measures of Disease Activity and Symptoms
Margaret H Collins, Lisa J Martin, Ting Wen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2013
IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop
Carine Bouffi, Mark Rochman, Christopher B Zust, et al.
Allergy
|
February 16, 2023
Protease allergens as initiators-regulators of allergic inflammation
Wai Tuck Soh, Jihui Zhang, Morley D Hollenberg, et al.
Blood
|
January 19, 2006
The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease
Yoshiyuki Yamada, Marc E Rothenberg, Andrew W Lee, et al.
The Journal of Allergy and Clinical Immunology
|
April 16, 2008
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels
Miguel L Stein, Joyce M Villanueva, Bridget K Buckmeier, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
August 9, 2020
Early life factors are associated with risk for eosinophilic esophagitis diagnosed in adulthood
Evan S Dellon, Olivia Shaheen, Nathaniel T Koutlas, et al.
Page
of 49